Synapse - Sarcoma Service

Results (953)

A multi-center radiomics-based model to differentiate between neurofibromatosis type 1-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors

Meeting Abstract

Ly, I.; Liu, T.; Cai, W.; Kwon, D.; Michaels, O.; Bredella, M.; Jordan, J.; Dombi, E.; Widemann, B.; Hirbe, A.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

nab-Sirolimus for patients with malignant perivascular epithelioid cell tumors

Journal Article

Wagner, A. J.; Ravi, V.; Riedel, R. F.; Ganjoo, K.; Van Tine, B. A.; Chugh, R.; Cranmer, L.; Gordon, E. M.; Hornick, J. L.; Du, H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Clinical activity of ripretinib in patients with advanced gastrointestinal stromal tumor harboring heterogeneous KIT/PDGFRA mutations in the phase III INVICTUS study

Journal Article

Bauer, S.; Heinrich, M. C.; George, S.; Zalcberg, J. R.; Serrano, C.; Gelderblom, H.; Jones, R. L.; Attia, S.; D'Amato, G.; Chi, P.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Retrospective world-wide registry on the efficacy of immune checkpoint inhibitors in alveolar soft part sarcoma: Updated results from sixty patients

Meeting Abstract

Hindi, N.; Rosenbaum, E.; Jonczak, E.; Hamacher, R.; Rutkowski, P.; Skryd, A.; Connolly, E.; Blay, J. Y.; Gutierrez, A.; Bogefors, C.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE)

Meeting Abstract

Schuetze, S.; Ballman, K. V.; Ganjoo, K. N.; Davis, E. J.; Morgan, J. A.; Tinoco, G.; Burgess, M. A.; Van Tine, B. A.; Choy, E.; Shepard, D. R.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Avelumab in patients with previously treated Merkel cell carcinoma (JAVELIN Merkel 200): Updated overall survival data after more than five years of follow up

Meeting Abstract

Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbe, C.; Lewis, K. D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Intra-patient dose escalation (IPDE) of ripretinib after disease progression in patients with advanced gastrointestinal stromal tumor (GIST): Analyses from the phase 3 INVICTUS study

Meeting Abstract

Zalcberg, J. R.; Heinrich, M. C.; George, S.; Bauer, S.; Schoffski, P.; Serrano, C.; Jones, R. L.; Gelderblom, H.; Attia, S.; D'Amato, G. Z.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

IGNYTE-ESO: A master protocol to assess safety and activity of letetresgene autoleucel (lete-cel; GSK3377794) in HLA-A*02+ patients with synovial sarcoma or myxoid/round cell liposarcoma (Substudies 1 and 2)

Meeting Abstract

D'Angelo, S. P.; Noujaim, J. C.; Thistlethwaite, F.; Razak, A. R. A.; Stacchiotti, S.; Chow, W. A.; Haanen, J. B. A. G.; Chalmers, A. W.; Robinson, S. I.; Van Tine, B. A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Phase (Ph) 1b/2 evaluation of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcoma (STS)

Meeting Abstract

Attia, S.; Villalobos, V. M.; Hindi, N.; Van Tine, B. A.; Wagner, A. J.; Chmielowski, B.; Levy, D. E.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Master protocol to assess safety and recommended phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma or non-small cell lung cancer (Substudies 1 and 2)

Meeting Abstract

Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S. P.; Ladle, B. H.; Noujaim, J. C.; He, K.; Liebner, D. A.; Sacher, A. G.; Haanen, J. B. A. G.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save